English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA randomized controlled trial of more than 800 adults diagnosed with COVID-19 found that combination therapy with amubarvimab plus romlusevimab significantly reduced the rates of hospitalization and death compared to placebo. The clinical benefit was similar regardless of whether therapy was given within 5 days or more than 5 days of symptom onset. The findings are published in Annals of Internal Medicine.
Tag: covid 19 and death
Despite fewer overall COVID-19 deaths, more younger people died in second year of the pandemic
A brief research report found that despite 20.8 percent fewer COVID-19 deaths occurring in the second year of the COVID-19 pandemic, 7.4 percent more years of life were lost due to a shift in COVID-19 mortality to relatively younger people. The report is published in Annals of Internal Medicine.